MedTrace Logo

The Effects of Pancreatic Enzyme Supplementation in Critically Ill Patients on Enteral Feeding

NCT05112328 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 170

Last updated 2021-11-08

No results posted yet for this study

Summary

Determine the effect of high-dose pancreatic enzyme supplementation on nutritional indicators and clinical course in critically ill patients undergoing enteral nutrition.

Conditions

  • Critically Ill
  • Enteral Feeding
  • Exocrine Pancreatic Insufficiency

Interventions

DRUG

Exocrine Pancreatic Enzyme

Pancreatic enzyme supplementation for critically ill patients on enteral nutrition

DRUG

Placebo

Placebo of Pancreatic enzyme for critically ill patients on enteral nutrition

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-07
Primary Completion
2026-07-31
Completion
2026-07-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05112328 on ClinicalTrials.gov